Trial · NCT03759665
Results by group26
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 26
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Clinical Impression of Change in Severity (CI-CS) [Fields et al 2021] | Parent Study | 0.71 | Standard Deviation 2.09 | score on a scale | |
| Key Secondary Endpoint: Individual Components of the CI-CS | Parent Study | Treatment with IB1001 | 0.34 | Standard Deviation 1.59 | score on a scale |
| Key Secondary Endpoint: Individual Components of the CI-CS | Parent Study | Post-TreatmentWashout | -0.36 | Standard Deviation 1.33 | score on a scale |
| Key Secondary Endpoint: Change in Severity Based on Average CI-S | Parent Study | 0.09 | Standard Deviation 0.71 | score on a scale | |
| Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point Scale | Parent Study | Treatment with IB1001 / -1 (Worsened) | 12 | Participants | |
| Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point Scale | Parent Study | Treatment with IB1001 / 0 (No observable change) | 1 | Participants | |
| Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point Scale | Parent Study | Treatment with IB1001 / +1 (Improved) | 16 | Participants | |
| Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point Scale | Parent Study | Post-treatment washout / -1 (Worsened) | 16 | Participants | |
| Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point Scale | Parent Study | Post-treatment washout / 0 (No observable change) | 3 | Participants | |
| Key Secondary Endpoint: CI-CS Score Reclassified on a 3-Point Scale | Parent Study | Post-treatment washout / +1 (Improved) | 8 | Participants | |
| Key Secondary Endpoint: CI-CS Score for the Non-Primary Anchor Test | Parent Study | Treatment with IB1001 | -0.30 | Standard Deviation 1.33 | score on a scale |
| Key Secondary Endpoint: CI-CS Score for the Non-Primary Anchor Test | Parent Study | Post-treatment washout | 0.23 | Standard Deviation 1.43 | score on a scale |
| Spinocerebellar Ataxia Functional Index (SCAFI) [Schmitz-Hübsch et al, 2008] | Parent Study | Treatment with IB1001 | 0.0163 | Standard Deviation 0.2749 | Z-scores |
| Spinocerebellar Ataxia Functional Index (SCAFI) [Schmitz-Hübsch et al, 2008] | Parent Study | Post-treatment washout | -0.0080 | Standard Deviation 0.2420 | Z-scores |
| Scale for Assessment and Rating of Ataxia (SARA) Score [Schmitz-Hübsch Etal, 2006; Subramony, 2007] | Parent Study | Treatment with IB1001 | -1.41 | Standard Deviation 1.67 | score on a scale |
| Scale for Assessment and Rating of Ataxia (SARA) Score [Schmitz-Hübsch Etal, 2006; Subramony, 2007] | Parent Study | Post-treatment washout | 1.43 | Standard Deviation 2.08 | score on a scale |
| EuroQuol- 5 Dimension (EQ-5D) Quality of Life Scale: Visual Analogue Scale (VAS) | Parent Study | Treatment with IB1001 | 71.3 | Standard Deviation 23.2 | score on a scale |
| EuroQuol- 5 Dimension (EQ-5D) Quality of Life Scale: Visual Analogue Scale (VAS) | Parent Study | Post-Treatment Washout | 71.1 | Standard Deviation 21.2 | score on a scale |
| Modified Disability Rating Scale (mDRS) [Iturriaga et al. 2006] | Parent Study | Treatment with IB1001 | -0.030 | Standard Deviation 0.075 | score on a scale |
| Modified Disability Rating Scale (mDRS) [Iturriaga et al. 2006] | Parent Study | Post-Treatment Washout | 0.042 | Standard Deviation 0.058 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03759665/results